This knot value is explained by the nearly complete depletion of liver glutathione and the resultant termination of AN detoxification. The toxicity of AN is known to increase sharply above this dose. The data suggest that a comparison of specific tissue proteins labeled by AN above and below this threshold dose may provide some insight into the mechanism of AN-induced toxicity.
AN is acutely toxic (Gut et al., 1981) . It is currently thought that three effects of AN may be responsible for acute toxicity. First, AN can be oxidatively metabolized in the liver via cytochrome P450 to cyanoethylene oxide, which can be metabolized further to release cyanide (Gut et al., 1984; Abreu and Ahmed, 1980) . Although cyanide (CN) is known to be 10 times more toxic than AN on a molar basis (Magos, 1962) , CN formation alone cannot explain all of the acute toxicity of AN. The median lethal dose of potassium cyanide can be raised threefold with the CN antidote, thiosulfate (Leung et al., 1986) . In contrast, thiosulfate produced only a 1.3-fold shift in the AN dose-response curve in the rat (Gut et al., 1981) and AN was lethal in rats whose blood CN levels have been reduced to near zero with thiosulfate (Hashimoto and Kanai, 1965) . A threefold shift can be produced in mice (Gut et al., 1981) , since the oxidative metabolism of AN to CN is more efficient in mice. As a result, the CN component to AN toxicity is more dominant in this species (Gut et al., 1981) . Since the rat's oxidative metabolism of AN is closer to that in the human (Roberts et al, 1991) , it is a better model for acute exposure studies. These considerations suggest that the parent AN molecule possesses its own toxicity.
Two biochemical effects of the parent molecule have been considered as potentially important to toxicity. The first is the observation that AN can cause depletion of glutathione (GSH) in virtually all tissues (Szabo et al., 1977; Benz et al., 1997) . How this effect may result in acute toxicity has not been established. Depletion of GSH alone would not be expected to be acutely lethal. This is evidenced by the fact that diethylmaleate (DEM), an excellent depletor of GSH, is not particularly toxic. A dose of about 2 mmol/kg DEM will cause over 80% depletion of liver GSH in rats (GerardMonnier et al., 1992) , while its LD50 is approximately 17 mmol/kg (Andersen et al., 1980) . A 1 mmol/kg (50 mg/kg) dose of AN will produce a similar depletion (Benz et al., 1997) , but its LD50 is only 1.6 mmol/kg (80 mg/kg) (Benz et al., 1990) . Obviously, it is not simply the depletion of GSH that makes AN acutely toxic.
The final biochemical effect of the parent AN molecule, 
FIG.
1. Dose-response curves for acrylonitrile covalent binding to tissue proteins. Each point represents the mean ± SE for 3-6 rats. The points represent data collected from rats that were sampled when the covalent binding had reached completion at each dose. The lines connect the points plotted. Where no error bars are visible, they are smaller than the symbol. which has been linked to toxicity, is its ability to nonenzymatically cyanoethylate cysteine and other amino acid residues in protein. The important protein targets of the cyanoethylation reaction, which result in toxicity, have not been determined. As a first step toward determining the specific protein targets in various tissues, we have carefully followed the dose dependence of AN covalent binding to tissue protein over a 100-fold range in dose. We observed a nonlinear dose-response curve with a break at approximately 1 mmol/ kg AN. This break is associated with a depletion of liver GSH and the resultant termination of AN detoxification. This may explain the sharp increase in toxicity above this dose.
MATERIALS AND METHODS
Chemicals. Acrylonitrile (>99% pure), containing 35-45 ppm hydroquinone monomethyl ether as a polymerization inhibitor, was purchased from Aldrich Chemical Co. (Milwaukee, Wl) . [2,3- u CJAN (>99% radiochemical purity) was obtained from Sigma Chemical Co. (St. Louis, MO) at a specific activity of 5.5 Ci/mol. Radiochemical purity was checked by HPLC prior to use. Heparin (sodium salt, grade 1; porcine intestinal mucosa) was purchased from Sigma Chemical Co. Pentafluorophenylisothiocyanate (PFPITC) was obtained from Fluka Chemical Corp. (Ronkonkoma, NY) and L-valine (d8, 98%) was obtained from Cambridge Isotope Laboratories, Inc. (Andover, MA). Ethyl acetate, 1-propanol, 2-propanol, acetone, and ethyl ether were purchased from Fisher Scientific Co. (Pittsburgh, PA). All other chemicals were of the highest quality available from commercial sources.
Animals. Male Sprague-Dawley rats, weighing between 225 and 249 g were obtained from Harlan (Indianapolis, IN). All animal were maintained on a 12-hr light-dark cycle at 22 ± 2°C. The rats were acclimated for at least 1 week prior to use and were allowed Punna Rat Chow (Ralston Purina Co., St. Louis, MO) and water ad libitum.
Animal treatment
Animal treatment was exactly as described previously (Benz et al., 1997) . The AN dose range was extended in the current study to include all of the following doses: 0.023 mmol/kg (1.2 mg/kg), C]AN so that each rat received 50 jjCi/kg. The AN was dissolved in distilled water and administered sc in the scruff of the neck. Control animals received distilled water only. All injection volumes were 5 ml/kg. Three or more animals were treated at each dose. Each animal was injected with the dose of AN between 9:00 and 10:00 AM, i.e., at the peak of the liver GSH diurnal rhythm (Jaeger et al., 1973) .
Tissue sampling and covalent binding analysis. Tissues were harvested 1 hr after AN administration at the three lowest doses. Covalent binding has reached completion by 1 hr at diese doses (Benz et al., 1997) . At the four highest doses, the tissues were harvested at 0.25, 0.5, 1.0, 2.0, and 4.0 hr after AN administration. All other procedures used in tissue sampling and processing of tissue homogenates for covalent binding analysis were exactly as previously described (Benz et al., 1997) .
Isolation of globin and analysis of total AN covalent binding. Erythrocytes were sedimented by centrifugation at 2100g for 10 min and the plasma was removed by aspiration. The packed erythrocytes were then washed three times with 0.9% saline. Samples of packed erythrocytes were lysed widi an equal volume of distilled water and the globin was isolated as described by Mowrer . The globin pellet was washed twice with ethanol and then once each with acetone, ethyl acetate, and diethyl ether to remove unbound radioactivity. The final pellet was then dried and a known weight (about 10 mg) was dissolved in 1.5 ml, 50 mM sodium acetate buffer, pH 4.8. A 1.0-ml aliquot was removed, mixed with Atomlight (DuPont NEN, Boston, MA), and assayed for covalently bound radioactivity by liquid scintillation spectrometry (Packard 2000CA, Downers Grove, IL), as described previously (Benz et al, 1997) . Covalently bound radioactivity was expressed as AN equivalents/g-globin by weight.
AN-valine adduct synthesis.
The analytical standard for the AN-valine adduct (A r -(2-cyanoethyl)valine, CEValine) was synthesized by incubating valine and AN in water at 80°C for 24 hr. Similarly, an internal standard, the AN adduct with d7-valine (CE-d7-valine), was synthesized by incubating d8-valine and AN in water at 80°C for 24 hr. Under these conditions the reactants were soluble in water. As the reaction proceeded a white crystalline precipitate was formed. After completion of the incubation, the mixtures were filtered to isolate the CEValine, and the crystals were washed with water and then methanol. Subsequent examination of the CEValine product by GC/MS, as the substituted phenylthiohydantoin derivative using the procedure detailed below, indicated it to be greater that 99% pure. During analysis of the stable isotope-labeled analog, it was noted that one deuterium atom of the d8-valine is lost to solvolysis during die reaction, yielding a CE-d7-valine adduct.
Quantilation of CEValine adducts. The N-terminal valine adducts were measured using a modified Edman degradation (Tomqvist et al., 1986) . FIG. 2. Dose-response curves for acrylonitrile covalent binding to globin. Each point represents the mean ± SE for 3-6 rats. The points represent data collected from rats that were sampled when the covalent binding had reached completion at each dose. The lines connect the points plotted. Where no error bars are visible, they are smaller than the symbol. The open squares (D) represent paired data collected from rats that were sampled at earlier time points when the covalent binding was still increasing as a function of time. Muscle covalent binding data were not available at the very highest levels of AN covalent binding. The curves illustrate the best fits to the hyperbolic function y = a^xla^ -x using the parameters listed in Table 2. dissolved in a solution of 1-propanol (0.5 ml) and 0.5 M KHC0 3 (1.0 ml). The internal standard (20 ng CE-d7-valine) and PFPITC (7 ^1) were added, and the mixture was vortexed for a few seconds to completely dissolve the PFPITC. The reaction was mixed overnight on an inverting rotator and then heated at 70°C for 2 hr. After cooling, the mixture was extracted with hexane (2x2 ml); the extracts were combined and then evaporated under nitrogen. The residue was redissolved in 1 ml of toluene and then washed with 2 ml 0.1 M K 2 CO 3 . The toluene phase was collected and evaporated under nitrogen. The residue was dissolved in 30 fx\ toluene, and 1 ii\ of this solution, containing the analytical derivative, l-cyanoethyl-5-isopropyl-3-phenyl-2-thiohydantoin (CETPTH), was analyzed by gas chromatography/ mass spectrometry/selective ion monitoring (GC/MS/SIM).
Instrumentation.
Adducts were quantified by GC/MS/SIM using a Hewlett Packard (HP) 5890 Series II GC coupled to a HP 5971 mass selective detector system. The GC/MS system was controlled and data were acquired by a HP Vectra QS20 personal computer running HP G1034C MS Chemstation software. The capillary GC column (DB-1, 12 m x 0.2 mm i.d. X 0.33 fim film thickness, J&W Scientific, Folson, CA) was terminated directly in the ion source. The chromatographic conditions were as follows: The helium carrier gas pressure in the injection port was maintained at 6 psi (40 kPa), and the injector temperature was 280°C. Samples (1 fi\) were analyzed in the splitless mode with a purge time of 1 min. The oven temperature, initially held at 120°C for 1 min, was programmed to increase at 20°C/min to a final temperature of 29O°C and then held at 29O°C for 0.5 min. Under these conditions the GC retention time of CEIPTH was 7.2 min. The GC/MS interface temperature was maintained at 280°C. Mass spectrometric conditions were standardized using an automatic ion source and quadrupole tuning routine that produced standard spectra for pentafluorotributylamine. Positive mass spectral ions formed by electron impact were monitored with dwell times of 75 msec each; these included mlz 311 (analyte) and mlz 384 (internal standard). The ratio of integrated peak areas (sample peak area/internal standard peak area) was linear with increasing analyte. Quantitation was based on a response factor determined from standard CEValine that had been subjected to this analysis.
Statistical analysis. Linear regression for dose-response data, with goodness of fit analysis used to test for linearity, was conducted using Instat version 2.0 (GraphPad Software, San Diego, CA). Differences between two regressions were tested according to Steel and Torrie (1960) Lower covalent binding (CB) range (0-6 ^mol AN eq/g-globin). * Entire covalent binding (CB) range (0-14 /jmol AN eq/g-globin). c Fit to hyperbolic function (y = a^xla^ -x).
''(/imol AN eq • g-protein"'//iraol AN eq-g-globin~'). * Intercepts were not significantly different from zero (p < 0.05). r Correlation coefficient ware, Carlsbad, CA) and The Scientist version 2.0 for Windows (MicroMath Scientific Software, Salt Lake City, UT).
RESULTS

Dose Response of Tissue Covalent Binding by AN
Covalent binding of AN to tissue protein has been observed to be time-dependent and reached completion by 1 -4 hr, depending on the AN dose (Benz et al., 1997 ). In the current study, this final level of binding was measured as a function of AN dose and the results are shown in Fig. 1 . The dose-response relationship was not linear throughout the entire dose range. Rather, a break appears at a AN dose of approximately 1 mmol/kg (50 mg/kg). Analysis of the dose-response relationship for each tissue, in the lower dose range (0.02-0.95 mmol AN/kg), indicated no significant deviation from linearity on goodness of fit analysis. The calculated slopes and correlation coefficients (r), in this dose range, are in Table 1 .
At higher AN doses, tissue covalent binding increased more steeply. Analysis of the dose-response relationship for each tissue, in this dose range (0.95-2.17 mmol AN/ kg), indicated no significant deviation from linearity on goodness of fit analysis. The calculated slopes and correlation coefficients, in this dose range, are in Table 1 . The slopes increased by 1.5-to almost 2-fold depending on the tissue. Goodness of fit analysis indicated significant deviation from linearity if the lower dose range was extended above 1 mmol AN/kg and if the upper dose range was extended below 1 mmol AN/kg. The data indicate a sublinear dose response with a knot value at about 1 mmol/kg AN.
Dose Response of the Formation of AN-Globin Adducts
Similar to the covalent binding to solid tissue protein, the formation of AN-globin adducts was time-dependent at each AN dose. In this study, the final level of covalent binding was measured. The dose dependence of globin total covalent binding and of the N-terminal CEValine adducts is shown in Fig. 2 . As observed for tissue protein, the doseresponse relationship was not linear throughout the entire dose range. However, goodness of fit analysis indicated that, in the lower dose range (0.02-0.95 mmol AN/kg), no significant deviation from linearity was evident for either adduct. The calculated slopes and correlation coefficients are in Table 1 .
At higher AN doses, the total covalent binding and particularly the level of CEValine adducts increased more steeply as a function of dose but only to 1.5 mmol/kg. Above this dose, unlike solid tissue covalent binding, globin adduct formation decreased. Analysis of the dose-response relationship, in this dose range (0.95-2.17 mmol AN/kg), indicated significant deviations from linearity on goodness of fit analysis (Table 1) .
Correlation of Tissue Covalent Binding of AN with Globin Total Covalent Binding
The regression of tissue covalent binding against globin total covalent binding is illustrated in Fig. 3 . Since covalent binding was a linear function of dose in the lower dose range (Figs. 1 and 2) , it was observed that, below 6 /xmol AN/gglobin (Fig. 3) , the data could be fit to a straight line, the calculated slopes and correlation coefficients of which are listed in Table 2 . For kidney and muscle, the linear relationship extended throughout the entire covalent binding range. For the other four tissues, the slopes increased with increasing levels of covalent binding. The entire data set could be fit to the hyperbolic function y = a x xlac -x ( Table 2) .
Correlation of Tissue Covalent Binding of AN with Globin CEValine Adduct Formation
The regression of tissue covalent binding against globin CEValine adduct formation is illustrated in Fig. 4 . For the same reason as stated above, it was observed that, below 0.012 /imol CEValine/g-globin, the data could be adequately fit to a straight line, the calculated slopes and correlation coefficients of which are listed in Table 3 . Above this level of adduct formation, the slopes decreased with increasing levels of covalent binding. The entire data set could be adequately fit to the hyperbolic function y = OQX/ a, + x (Table 3) .
DISCUSSION
The dose-response relationship for tissue covalent binding ( Figs. 1 and 2) indicated that, in the lower dose range, Table 3. covalent binding could be adequately described as a linear function of the dose. The slopes of the dose-response curves indicated that tissues varied by nearly 10-fold in their reactivity with AN (Table 1) . In this dose range, tissues can be grouped into three response categories: high (blood), intermediate (kidney, liver, forestomach, brain, glandular stomach), and low (muscle). Based on tissue classifications used in physiologically based pharmacokinetic models, liver, kidney, brain, and stomach are highly perfused tissues, while muscle is considered as being poorly perfused (Gargas et ai, 1995) . However, significant differences in covalent binding between tissues in the well perfused category were observed. The slopes in Table 1 indicated that the level of covalent binding for the seven tissues examined were as follows: blood > kidney = liver > forestomach = brain > glandular stomach $> muscle. Slopes not connected by an equal sign were statistically different (p < 0.05).
In addition to blood flow, another factor that controls the tissue distribution of AN covalent binding is the protein composition of the various tissues. Individual protein levels and their inherent reactivity with AN will play an important role. The very high covalent binding in blood can be accounted for by the high abundance and high reactivity of rat hemoglobin with electrophiles. The rat hemoglobin binding index (fimol adduct • g-globin~ Vmmol • kg" 1 ) for acrylamide was reported to be 6.4 (Bergmark et ai, 1991) , the highest value reported at that time. For AN, we measured a value of 6.48 (Table 1) . These levels of adduct formation are probably due to a highly reactive cysteine residue at position 0-125 in rat hemoglobin (Hughes et al., 1981; Skipper and Tannenbaum, 1990) , in addition to the reactive /0-93 found in most vertebrate hemoglobins. Electrospray ionization mass spectrometry of globin isolated from AN-treated rats revealed extensive cyanoethylation of the /3-chains (Stevens et al., 1994) . Acid hydrolysis of globin isolated from rats treated with a 4 mg/kg dose of [2,3-' 4 C]AN demonstrated that the major peak of radioactivity was associated with S-(2-carboxyethyl)cysteine. This indicated that cysteine is the major alkylation site on rat hemoglobin (Fennell et al., 1991) . The portion of the total globin covalent binding that can be attributed to the valine adduct can be determined from the slopes in Table 1 . The magnitude of the slope for the formation of the CEValine adduct compared to die slope for globin total covalent binding indicated that this product accounts for only 0.2%. Whether AN adduction to hemoglobin is involved in AN toxicity is not known. In addition, the identity of the proteins to which AN binds in the other tissues and how this covalent binding may affect their function is also unknown.
The regression of tissue covalent binding against hemoglobin adduct formation (Figs. 3 and 4) indicated that either globin biomarker could be used as a surrogate to estimate the amount of AN bound to protein in individual tissues following an acute exposure. However, because of the unusually high reactivity of the cysteines in rat globin versus other vertebrate species, the standard curve of tissue protein binding against the CEValine adduct would be more useful for estimating the tissue body burden. This conclusion is strengthened since, for other electrophiles (Segerback, 1990; Segerback et al., 1994) , the reactivity with the N-terminal valines of rat and human hemoglobin are comparable. Although the type of AN exposure was different, CEValine adduct levels in humans have been reported that are similar to those measured here. Bergmark et al. (1993) and Calleman etal. (1994) reported values in globin isolated from workers who use AN in the production of acrylamide in the People's Republic of China. The adduct levels they reported are in the range covered in Fig. 4 . Values as high as 0.03-0.06 /imol CEValine/g-globin were measured in a single individual. The human data represent cumulative covalent binding of AN rather than binding due to a single acute exposure as studied here. However, experiments in rats with acrylamide (Bergmark et al., 1991) indicated that the level of globin adducts measured following a single acute exposure at a high dose differed by only twofold from those measured when the same total dose was spread over 30 days. If die reactivity of AN with tissue proteins is comparable between die rat and the human, as is the case for the N-terminal valines on globin, then the standard curves in Fig. 4 could be used to estimate the tissue body burden of AN in humans.
Analysis of the dose-response relationship of tissue covalent binding by AN over the entire dose range indicated significant nonlinearity (Fig. 1) . Similar nonlinearities have been observed in the dose-response curves for hemoglobin adduct formation with AN (Fennell et al., 1991) and other electrophiles (Walker et al, 1993; Osterman-Golkar et al., 1995) . In the case of AN, a break in die dose-response curve occurred at one-tenth the dose reported here. In that experiment, the oral route was used and die disposition of AN following oral administration is different man by other routes (Gut et al., 1975) . Such nonlinearities often represent absorption, metabolism, or excretion pathways that exhibit saturable processes. In the present case, a well-defined knot value in the dose-response curve at the AN dose of approximately 1 mmol/kg was observed. It has been reported that at this dose (=50 mg/kg), liver GSH is 85% depleted (Benz et al., 1997) . The remaining 15% is largely restricted to the mitochondria (Reed and Savage, 1995) . Since conjugation with cytosolic GSH in liver is the major route of AN detoxification, it is not surprising that a break in the dose-response curves would occur at this dose.
In conclusion, we have found significant differences in AN's ability to covalently bind to protein in various tissues. A regression of tissue covalent binding against globin adducts in blood indicated that these adducts may be used as biomarkers to estimate AN tissue body burden. Finally, a knot point in the dose-response curve for AN covalent binding to tissue protein was observed. Above this dose, AN toxicity increases sharply. Our results suggest that comparison of the specific tissue proteins labeled above and below this critical dose may provide some insight into the mechanism of acute AN toxicity.
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